l carnitine atherosclerosis Meat-metabolizing bacteria in γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Figure 2 from The origin of trimethylamine N oxide (TMAO) and its role in development of atherosclerosis Semantic Scholar l carnitine tmao nature medicine 2013 koeth Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Cell Cardiovascular risk of dietary trimethylamine Dietary l carnitine accelerates atherosclerosis and inhibits reverse Download Scientific Diagram
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



